首页> Transplant international : official journal of the European Society for Organ Transplantation> T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation - An Observational Cohort Study.

T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation - An Observational Cohort Study.

导出 OA

翻译打印收藏纠错

第一作者： Simon,Aberger

第一单位： Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.;Department of Internal Medicine I, Nephrology, Paracelsus Medical University, Salzburg, Austria.

作者： Simon,Aberger ^[1] ; Max,Schuller ^[2] ; Agnes A,Mooslechner ^[3] ; Konstantin A,Klötzer ^[2] ; Barbara,Prietl ^[4] ; Verena,Pfeifer ^[4] ; Alexander H,Kirsch ^[2] ; Alexander R,Rosenkranz ^[2] ; Katharina,Artinger ^[2] ; Kathrin,Eller ^[2]

作者单位： Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.;Department of Internal Medicine I, Nephrology, Paracelsus Medical University, Salzburg, Austria. ^[1] Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. ^[2] Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.;Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Graz, Austria. ^[3] Center for Biomarker Research in Medicine, Graz, Austria.;Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. ^[4]

关键词 immune monitoring immunosuppression kidney transplantation personalized medicine translational nephrology